Clinical trial
Safety and Efficacy of Nebulized Nasal Steroids for the Treatment of Chronic Rhinosinusitis
NCT07270302 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Nebulized Nasal Steroids for the Treatment of Chronic Rhinosinusitis
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- December 31, 2025
- Completion date
- May 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinosinusitis